可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Beige J, Weber A, Engeli S, et al. AngiotensinogenM235T genotype and posttransplant hypertension[J]. Neph Dial Trap, 1996,11(8):1538-1541.
[2]Junemaitre X, Inoue I, Willians C, et al. Haplotype of angiotensinogen in essential hypertension[J]. Am J Hum Genet, 1997, 60(6)∶1448-1460.
[3]Sethi AA, Nordestgaard BG, TybjaeHansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease:a metaanalysis[J]. Arterioscler Thromb Vasc Biol,2003,23(7):1269-1275.
[4]陈鹏,江艳芬,程康. 中国原发性高血压患者血管紧张素原M235T 多态性Meta 分析[J]. 中华流行病学杂志,2003,24(8):711-714.
[5]卓玛次仁,庄兰平,崔超英,等. 藏族原发性高血压的遗传学研究[J]. 中华医学杂志,2002,82(15):1009-1012.
[6]Pereira AC,Mota GF,Cunha RS,et al. Angiotensinogen 235T allele “Dosage” is associated with blood pressure phenotypes[J]. Hypertension,2003,41(1):25-30.
[7]Brand E, Chatelain N, Paillard F, et al. Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregationlinkage analysis[J]. Eur J Hum Genet, 2002, 10(11):715-723.